Home Applications 205692 Application 205692
Type BLA
Sponsor ELI LILLY AND CO Purple Book Biologic Products# BLA, Proprietary name, Proper name table BLA Proprietary name Proper name License type Status Latest source 205692 Basaglar insulin glargine 351(a) Disc 2026-07-01
Application Products# Product, Drug, Ingredient table Product Drug Ingredient Form Strength Reference drug Reference standard 001 BASAGLAR INSULIN GLARGINE SOLUTION;SUBCUTANEOUS 300 UNITS/3ML (100 UNITS/ML) No No
openFDA label cross-check# OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
Matched openFDA labels page 1 of 1 · 1 matching rows.
NDC Listings For This Application# NDC listings for this application page 1 of 1 · 15 matching rows.
NDC, Name, Nonproprietary name table NDC Name Nonproprietary name Labeler Marketing category Status 0002-7715 BASAGLAR Insulin glargine Eli Lilly and Company NDA Current 0002-7715 BASAGLAR Insulin glargine Eli Lilly and Company BLA Current 0002-7715 BASAGLAR Insulin glargine Eli Lilly and Company BLA Current 0002-7715 BASAGLAR Insulin glargine Eli Lilly and Company BLA Current 0002-7715 BASAGLAR Insulin glargine Eli Lilly and Company NDA Current 0002-7715 BASAGLAR Insulin glargine Eli Lilly and Company BLA Current 0002-7715 BASAGLAR Insulin glargine Eli Lilly and Company NDA Current 0002-7715 BASAGLAR Insulin glargine Eli Lilly and Company BLA Current 0002-8214 BASAGLAR Insulin glargine Eli Lilly and Company BLA Current 0002-8214 BASAGLAR Insulin glargine Eli Lilly and Company BLA Current 0002-8214 BASAGLAR Insulin glargine Eli Lilly and Company BLA Current 0002-8214 BASAGLAR Insulin glargine Eli Lilly and Company NDA Current 0002-8214 BASAGLAR Insulin glargine Eli Lilly and Company BLA Current 0002-8214 BASAGLAR Insulin glargine Eli Lilly and Company NDA Current 0002-8214 BASAGLAR Insulin glargine Eli Lilly and Company BLA Current